SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1815)10/17/2000 11:33:04 AM
From: Biomaven  Read Replies (2) of 2001
 
this appears to be alteration with guidance and intent

It does seem to be stretching coincidence too far that this happened by chance. The most benign explanation I can think of is that there are recognizably different patterns of scarring in the treatment vs. placebo MRI's and the reader (who was supposedly blinded) was consistently responding to those differences. Note that the reader might still not know which pattern went with the treated patients and which with the placebos.

Of course there are considerably less benign explanations at well, all the way up to outright fraud.

Personally I think the stock is too cheap at these levels, and patient buyers with strong stomachs will likely be rewarded.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News